指南与共识复苏、休克与脓毒症重症综合管理与镇静镇痛

难治性脓毒性休克的临床定义标准:SCCM与ESICM联合德尔菲共识

Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM).
指南 / 共识 · Crit Care Med · 2026-03-24
一句话结论SCCM与ESICM联合德尔菲共识提出13条标准定义难治性脓毒性休克:液体无反应、去甲肾上腺素当量>0.5 µg/kg/min,伴乳酸持续升高和/或毛细血管再充盈时间延长,怀疑混合性休克时行重症超声评估。

该共识由SCCM与ESICM组织56名多国多专业重症专家,经五轮德尔菲流程对34条陈述进行共识,最终29条中13条达成共识。共识认定难治性脓毒性休克的临床标准包括器官功能障碍标志物、组织灌注标志物(乳酸、毛细血管再充盈时间)、初始复苏后液体反应性评估,以及去甲肾上腺素当量>0.5 µg/kg/min的血管活性药物使用。重症超声是唯一达成共识的诊断方式。该共识为难治性脓毒性休克的诊断、管理、预后判断和未来研究提供了标准化框架。

要点

  • 难治性脓毒性休克需同时满足:液体无反应、去甲肾上腺素当量>0.5 µg/kg/min,伴乳酸持续升高和/或毛细血管再充盈时间延长。
  • 组织灌注标志物获91.1%共识(2轮),其中乳酸94.6%(2轮)、毛细血管再充盈时间76.8%(2轮)。
  • 初始复苏后液体反应性评估获92.9%共识(5轮),是定义难治性休克的关键环节。
  • 去甲肾上腺素当量>0.5 µg/kg/min获75.0%共识(3轮),作为血管活性药物使用强度的阈值。
  • 重症超声获92.9%共识(3轮),是唯一达成共识的诊断方式,用于怀疑混合性休克时评估。

适用人群与场景

  • 脓毒性休克患者,处于初始复苏后评估阶段。

诊断标准与关键阈值

  • 难治性脓毒性休克的临床标准包括:器官功能障碍标志物(75%,2轮)、组织灌注标志物(91.1%,2轮)含乳酸(94.6%,2轮)和毛细血管再充盈时间(76.8%,2轮)、初始复苏后液体反应性评估(92.9%,5轮)、去甲肾上腺素当量>0.5 µg/kg/min的血管活性药物使用(75.0%,3轮)。
  • 难治性脓毒性休克特征为:液体无反应、需要去甲肾上腺素基础当量>0.5 µg/kg/min、乳酸持续升高和/或毛细血管再充盈时间延长,怀疑混合性休克时行重症超声评估。

处置流程与药物剂量

  • 初始复苏后评估液体反应性(92.9%,5轮)。
  • 使用血管活性药物,去甲肾上腺素当量>0.5 µg/kg/min(75.0%,3轮)。
  • 监测组织灌注标志物,包括乳酸和毛细血管再充盈时间。
  • 怀疑混合性休克时行重症超声评估(92.9%,3轮)。

研究设计与关键结果

  • SCCM与ESICM组织56名多国多专业重症专家参与五轮德尔菲流程,对34条陈述进行共识,第二轮后5条被否决,29条中13条达成共识。
  • 共识阈值定义为至少75%专家在7点Likert量表最高或最低三级达成一致或分歧。
  • 器官功能障碍标志物共识度75%(2轮),组织灌注标志物91.1%(2轮),乳酸94.6%(2轮),毛细血管再充盈时间76.8%(2轮),液体反应性评估92.9%(5轮),去甲肾上腺素当量>0.5 µg/kg/min共识度75.0%(3轮),重症超声92.9%(3轮)。

证据类型、等级与局限

  • 证据类型:指南/共识(德尔菲共识),由SCCM与ESICM联合制定。
  • 共识定义:至少75%专家在7点Likert量表最高或最低三级达成一致或分歧。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对脓毒性休克患者,初始复苏后应评估液体反应性,液体无反应且去甲肾上腺素当量>0.5 µg/kg/min、伴乳酸持续升高和/或毛细血管再充盈时间延长时,可考虑难治性脓毒性休克。
  • 怀疑混合性休克时,可行重症超声评估。

指南或共识出处

  • Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM),发表于Critical Care Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: A definition of refractory septic shock is necessary to guide diagnosis, management, prognostication, research, and future guidelines for this most severe form of the disease. We sought to achieve consensus on clinical criteria that would be used to define refractory septic shock.

DESIGN: Review of literature, expert panel position statements, and Delphi rounds with an international expert group.

SETTING: Consensus was defined as having at least 75% of panellists in agreement or disagreement on the three highest or lowest levels of a 7-point Likert scale or based on responses to single- or multiple-choice questions, respectively.

SUBJECTS: A panel of multinational, multiprofessional and multidisciplinary critical care experts assembled by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine (57 invitations and 56 participants).

MEASUREMENTS AND MAIN RESULTS: A five-round Delphi process was conducted for consensus and stability. The steering committee proposed 34 statements, and five of them were rejected by panel experts after round 2. Among 29 statements selected from eight domains, consensus was reached for 13. The panel agreed on the need for a comprehensive consensus set of clinical criteria for refractory septic shock. Markers of organ dysfunction (75%, 2 rounds), tissue perfusion (91.1%, 2 rounds) including lactate (94.6%, 2 rounds) and capillary refill time (76.8%, 2 rounds), assessment of fluid-responsiveness after initial resuscitation (92.9%, 5 rounds), and use of vasoactive drugs at norepinephrine equivalents greater than 0.5 µg/kg/min (75.0%, 3 rounds), were selected as clinical criteria of refractory septic shock. The use of critical care ultrasound (CCUS) (92.9%, 3 rounds) was the single diagnostic modality that reached a consensus-based agreement.

CONCLUSIONS: A consensus for 13 criteria to frame the definition of refractory septic shock was reached. Refractory septic shock is characterised by persistently elevated lactate concentrations and or prolonged capillary refill time in patients with septic shock who are fluid unresponsive, require a norepinephrine base equivalent dose greater than 0.5 micrograms per kilogram per minute, and undergo CCUS assessment when mixed shock is suspected.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Leone M, Myatra SN, Dugar S, et al. Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM). Crit Care Med. 2026. PMID: 41873857. doi:10.1097/CCM.0000000000007124

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。